HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria E Figueiredo-Pereira Selected Research

9-deoxy-delta-9-prostaglandin D2

1/2020PACAP27 mitigates an age-dependent hippocampal vulnerability to PGJ2-induced spatial learning deficits and neuroinflammation in mice.
9/2018Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
1/2018Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by α- and β-secretases: relevance to Alzheimer's disease.
1/2016Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
10/2012cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons.
7/2009Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.
7/2009Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.
8/2006Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates.
7/2006Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells.
5/2006Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria E Figueiredo-Pereira Research Topics

Disease

17Inflammation (Inflammations)
04/2022 - 05/2003
12Neurodegenerative Diseases (Neurodegenerative Disease)
02/2018 - 07/2002
9Alzheimer Disease (Alzheimer's Disease)
04/2022 - 07/2004
6Neuroinflammatory Diseases
01/2020 - 01/2006
6Parkinson Disease (Parkinson's Disease)
01/2019 - 07/2004
4Neuroblastoma
07/2009 - 06/2005
3Stroke (Strokes)
04/2022 - 01/2014
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2014 - 07/2004
2Spinal Cord Injuries (Spinal Cord Injury)
01/2016 - 10/2012
1Amyloid Plaque
04/2022
1Asthma (Bronchial Asthma)
04/2022
1Memory Disorders (Memory Loss)
01/2020
1Gliosis
02/2018
1Cognitive Dysfunction
02/2018
1Ataxia (Dyssynergia)
01/2017
1Down Syndrome (Down's Syndrome)
01/2016
1Pathologic Processes
01/2016
1Pick Disease of the Brain (Pick's Disease)
01/2016
1Myocardial Infarction
09/2014
1Encephalitis (Encephalitis, Rasmussen)
09/2014
1Globoid Cell Leukodystrophy (Krabbe Disease)
01/2014
1Demyelinating Diseases (Demyelinating Disease)
01/2014
1Brain Injuries (Brain Injury)
01/2014
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2014
1Mitochondrial Diseases (Mitochondrial Disease)
04/2013
1Tauopathies
04/2013
1Dehydration (Water Stress)
07/2009
1Necrosis
10/2007

Drug/Important Bio-Agent (IBA)

12UbiquitinIBA
04/2022 - 05/2003
12Proteasome Endopeptidase Complex (Proteasome)IBA
04/2022 - 05/2003
119-deoxy-delta-9-prostaglandin D2IBA
01/2020 - 06/2005
11Proteins (Proteins, Gene)FDA Link
01/2018 - 07/2004
10Ubiquitinated ProteinsIBA
01/2017 - 07/2002
7ProstaglandinsIBA
01/2020 - 07/2004
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2020 - 01/2014
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2018 - 05/2003
2Pharmaceutical PreparationsIBA
04/2022 - 02/2018
2Prostaglandin D2IBA
09/2018 - 07/2009
2Cyclooxygenase InhibitorsIBA
09/2018 - 01/2016
2Amyloid (Amyloid Fibrils)IBA
01/2018 - 12/2007
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016 - 09/2014
2Protein AggregatesIBA
09/2013 - 07/2006
1ibudilastIBA
04/2022
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2020
1CalciumIBA
01/2019
1Ibuprofen (Motrin)FDA LinkGeneric
09/2018
1Methamphetamine (Desoxyn)FDA LinkGeneric
02/2018
1Protein Kinases (Protein Kinase)IBA
02/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2018
1Amyloid beta-PeptidesIBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Small Interfering RNA (siRNA)IBA
01/2017
1Amino AcidsFDA Link
01/2016
1EnzymesIBA
01/2016
1PK 11195 (PK11195)IBA
09/2014
1CalpainIBA
04/2013
1ATP dependent 26S protease (26S proteasome)IBA
04/2013
1Adenosine Triphosphate (ATP)IBA
04/2013
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2013
1cyclopentenoneIBA
07/2009
1Cytotoxins (Cytolysins)IBA
07/2009
1CaspasesIBA
07/2009
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2007
1RotenoneIBA
08/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2006
1Cysteine (L-Cysteine)FDA Link
07/2006
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
05/2006
1Phosphotransferases (Kinase)IBA
01/2006
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2006
1CytokinesIBA
12/2004
1Interleukin-1 (Interleukin 1)IBA
12/2004
1delta(12)-prostaglandin J(2)IBA
07/2004
1HydrolasesIBA
07/2004
1Inflammation MediatorsIBA
07/2004

Therapy/Procedure

2Therapeutics
09/2014 - 01/2006